Sarah Cannon has announced the promotion of Dr. Melissa Johnson to program director of lung cancer research.
Since joining Nashville-based Sarah Cannon in 2014, Johnson (pictured) has served as the associate director of lung cancer research at Sarah Cannon Research Institute (the research arm of Sarah Cannon), supporting the growth of early-phase compounds in thoracic malignancies. In her new role, she will lead the lung cancer clinical trial portfolio across the Sarah Cannon network.
Johnson will continue to work in early-phase drug development as well as lead the solid tumor immune effector cellular therapy program at Sarah Cannon. She also serves as the chair of the cancer committee at TriStar Centennial Medical Center and served as the scientific committee program chair for the American Society of Clinical Oncology annual meeting earlier this year.
Shore Fire Media
Multi-PLATINUM selling artist Justin Moore and powerhouse independent music publisher Big Machine Music announce the extension of their long-term, exclusive music publishing agreement. As one of the founding artist-songwriters initially signed to BMM (then Super 98 Music), Moore has co-written five of his nine No. 1 songs as an artist. His most recent chart-topper “Why We Drink” marked BMM’s 35th run in the pinnacle spot on Country radio.
“Loyalty and friendship are things I learned to really value from my parents and hope my own kids appreciate,” shared Moore. “These moments are another reminder of the people who have believed in me and continue to invest. Thank you, Mike and everyone at Big Machine Music as we create more stories through song.”